77 related articles for article (PubMed ID: 2431492)
1. Somatostatin analog: effects on hypergastrinemia and hypercalcitoninemia.
Geelhoed GW; Bass BL; Mertz SL; Becker KL
Surgery; 1986 Dec; 100(6):962-70. PubMed ID: 2431492
[TBL] [Abstract][Full Text] [Related]
2. Observations on the effect of a somatostatin analog in the Zollinger-Ellison syndrome: implications for the treatment of apudomas.
Ellison EC; O'Dorisio TM; Sparks J; Mekhjian HS; Fromkes JJ; Woltering EA; Carey LC
Surgery; 1986 Aug; 100(2):437-44. PubMed ID: 2426819
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin receptor expression in vivo and response to somatostatin analog therapy with or without other antineoplastic treatments in advanced medullary thyroid carcinoma.
Vainas I; Koussis Ch; Pazaitou-Panayiotou K; Drimonitis A; Chrisoulidou A; Iakovou I; Boudina M; Kaprara A; Maladaki A
J Exp Clin Cancer Res; 2004 Dec; 23(4):549-59. PubMed ID: 15743023
[TBL] [Abstract][Full Text] [Related]
4. Suppression of primary and secondary peptides with somatostatin analog in the therapy of functional endocrine tumors.
Woltering EA; Mozell EJ; O'Dorisio TM; Fletcher WS; Howe B
Surg Gynecol Obstet; 1988 Dec; 167(6):453-62. PubMed ID: 2460958
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin analogue (SMS 201-995) in patients with gastrinomas.
Vinik AI; Tsai S; Moattari AR; Cheung P
Surgery; 1988 Nov; 104(5):834-42. PubMed ID: 2903562
[TBL] [Abstract][Full Text] [Related]
6. [Usefulness of the somatostatin analog SMS 201-995 in the treatment of gastrinoma].
Gilsanz Peral A; Costa Talens P; Gómez Balaguer M
Med Clin (Barc); 1987 Jun; 89(3):131-2. PubMed ID: 2887718
[No Abstract] [Full Text] [Related]
7. The use of octreotide in the treatment of medullary thyroid carcinoma.
Frank-Raue K; Ziegler R; Raue F
Horm Metab Res Suppl; 1993; 27():44-7. PubMed ID: 8330871
[TBL] [Abstract][Full Text] [Related]
8. Clinical evaluation of SMS 201-995. Long-term treatment in gut neuroendocrine tumours, efficacy of oral administration, and possible use in non-tumoural inappropriate TSH hypersecretion.
Williams G; Anderson JV; Williams SJ; Bloom SR
Acta Endocrinol Suppl (Copenh); 1987; 286():26-36. PubMed ID: 2892335
[TBL] [Abstract][Full Text] [Related]
9. Use of somatostatin analog SMS 201-995 in medullary thyroid carcinoma.
Libroia A; Verga U; Di Sacco G; Piolini M; Muratori F
Henry Ford Hosp Med J; 1989; 37(3-4):151-3. PubMed ID: 2576951
[TBL] [Abstract][Full Text] [Related]
10. Relations of calcitonin and gastrin in the Zollinger-Ellison syndrome and medullary carcinoma of the thyroid.
Sizemore GW; Go VL; Kaplan EL; Sanzenbacher LJ; Holtermuller KH; Arnaud CD
N Engl J Med; 1973 Mar; 288(13):641-4. PubMed ID: 4734496
[No Abstract] [Full Text] [Related]
11. [Therapy of metastatic medullary thyroid gland carcinoma with the somatostatin analog octreotide].
Frank-Raue K; Raue F; Ziegler R
Med Klin (Munich); 1995 Feb; 90(2):63-6. PubMed ID: 7708002
[TBL] [Abstract][Full Text] [Related]
12. Prospective study of the antitumor efficacy of long-term octreotide treatment in patients with progressive metastatic gastrinoma.
Shojamanesh H; Gibril F; Louie A; Ojeaburu JV; Bashir S; Abou-Saif A; Jensen RT
Cancer; 2002 Jan; 94(2):331-43. PubMed ID: 11900219
[TBL] [Abstract][Full Text] [Related]
13. The use of a long-acting somatostatin analogue in the treatment of advanced endocrine malignancies with gastrointestinal symptoms.
Ahlman H; Tisell LE
Scand J Gastroenterol; 1987 Oct; 22(8):938-42. PubMed ID: 2891186
[TBL] [Abstract][Full Text] [Related]
14. Perioperative use of long-acting somatostatin analog (SMS 201-995) in patients with endocrine tumors of the gastroenteropancreatic axis.
Tsai ST; Eckhauser FE; Thompson NW; Strodel WE; Vinik AI
Surgery; 1986 Oct; 100(4):788-95. PubMed ID: 2876529
[TBL] [Abstract][Full Text] [Related]
15. Effects of short-term subcutaneous administration of SMS 201-995 on calcitonin plasma levels in patients suffering from medullary thyroid carcinoma.
Guliana JM; Guillausseau PJ; Caron J; Siame-Mourot C; Calmettes C; Modigliani E
Horm Metab Res; 1989 Oct; 21(10):584-6. PubMed ID: 2807148
[No Abstract] [Full Text] [Related]
16. Effect of a somatostatin analog (SMS 201-995) in perfusion on basal and pentagastrin-stimulated calcitonin levels in medullary thyroid carcinoma.
Modigliani E; Chayvialle JA; Cohen R; Perret G; Guliana JM; Vassy R; Roger P; Siame-Mourot C; Bennet M; Bentata-Pessayre M
Horm Metab Res; 1988 Dec; 20(12):773-5. PubMed ID: 2906036
[No Abstract] [Full Text] [Related]
17. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.
Nikou GC; Lygidakis NJ; Toubanakis C; Pavlatos S; Tseleni-Balafouta S; Giannatou E; Mallas E; Safioleas M
Hepatogastroenterology; 2005; 52(63):731-41. PubMed ID: 15966194
[TBL] [Abstract][Full Text] [Related]
18. Somatostatin analogs in the treatment of medullary thyroid carcinoma.
Díez JJ; Iglesias P
J Endocrinol Invest; 2002 Oct; 25(9):773-8. PubMed ID: 12398235
[TBL] [Abstract][Full Text] [Related]
19. Medullary thyroid carcinoma and hormones.
Cohen R; Quidville V; Bihan H
Ann Med Interne (Paris); 2003 Mar; 154(2):109-16. PubMed ID: 12746649
[TBL] [Abstract][Full Text] [Related]
20. Use of a somatostatin analog (SMS 201-995) in the glucagonoma syndrome.
Altimari AF; Bhoopalam N; O'Dorsio T; Lange CL; Sandberg L; Prinz RA
Surgery; 1986 Dec; 100(6):989-96. PubMed ID: 2878500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
